ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
7.57%
↑ 333% vs avg
Percentile
P70
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-3.25%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 7.57% |
| Q3 2025 | -18.83% |
| Q2 2025 | 2.82% |
| Q1 2025 | -197.00% |
| Q4 2024 | 390.34% |
| Q3 2024 | -98.75% |
| Q2 2024 | -8.48% |
| Q1 2024 | 61.45% |
| Q4 2023 | -36.37% |
| Q3 2023 | 23.43% |
| Q2 2023 | -34.11% |
| Q1 2023 | 39.36% |
| Q4 2022 | -260.74% |
| Q3 2022 | 18.53% |
| Q2 2022 | -0.71% |
| Q1 2022 | 67.50% |
| Q4 2021 | -11.43% |
| Q3 2021 | -35.26% |
| Q2 2021 | -15.85% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q2 2020 | 28.64% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |